Please login to the form below

Not currently logged in
Email:
Password:

SOBI

This page shows the latest SOBI news and features for those working in and with pharma, biotech and healthcare.

Shire claims EU approval for haemophilia A drug Adynovi

Shire claims EU approval for haemophilia A drug Adynovi

Shire claims EU approval for haemophilia A drug Adynovi. The drug will battle Bayer’s Kovaltry and Sobi's Elocta in a bid to capture market share. ... It is jostling for market share with other long-acting Factor VIII products for haemophilia A,

Latest news

More from news
Approximately 5 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • A rare opportunity A rare opportunity

    A rare opportunity. Sobi’ s Neil Dugdale on how the UK’ s approach to rare diseases is changing. ... An exciting time. For Neil's company Sobi it's certainly been a busy time this year.

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Sobi poaches Pfizer’ s Fredrick Wetterlundh. He joins the speciality healthcare group as head of human resources. ... Swedish Orphan Biovitrum (Sobi) has appointed Fredrik Wetterlundh as head of human resources and will simultaneously be part of

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Mereo BioPharma appoints head of patient access and commercial planning. Wills Hughes-Wilson joins the group from Sobi. ... In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    Rare disease firm Sobi has appointed Holly May as its new vice president of sales and marketing for the US. ... May’s new role will see her lead the biopharma’s commercial team in bringing Sobi ’s medicines to the country.

  • Relay Therapeutics appoints Sarah O’Brien as VP of HR Relay Therapeutics appoints Sarah O’Brien as VP of HR

    Relay Therapeutics appoints Sarah O’ Brien as VP of HR. She joins the biotech from Sobi. ... She joins the biotech from Sobi in North America, where she was responsible for a variety of global initiatives across learning, development and culture.

  • Sobi appoints Torbjorn Hallberg as general counsel Sobi appoints Torbjorn Hallberg as general counsel

    Sobi appoints Torbjorn Hallberg as general counsel. He joins the rare diseases healthcare group from Takeda. ... Swedish healthcare group Sobi has appointed Torbjorn Hallberg as its new general counsel and establishes a new leadership structure.

More from appointments
Approximately 8 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics